TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (Cybin or the Company), a biotechnology company focused on progressing Psychedelics to Therapeutics, is pleased to announce that Adelia Therapeutics Inc. (Adelia), a wholly-controlled…
